Akademik Veri Yönetim Sistemi
Turk Hijyen ve Deneysel Biyoloji Dergisi, cilt.74, sa.1, ss.21-28, 2017 (Scopus)
Objective: In this study, it was aimed to investigate seroprevalence of hepatitis B surface antigen (HBsAg), hepatitis B surface antibody (anti-HBs), hepatitis B core antibody (anti-HBcIgG), hepatitis C surface antibody (anti-HCV) and hepatitis A virus antibody (anti-HAV IgG) in pregnant women admitted to Izmir Aegean Obstetrics and Gynecology Training and Research Hospital. Methods: This study was planned as a descriptive study. 2003 pregnant women, who admitted to pregnancy clinic of Izmir Aegean Maternity and Gynaecology Training and Research Hospital and were directed to blood drawing centre between December 01, 2010 and September 30, 2011 were included in the study. A written consent form was obtained from whom accepted to participate in the study. A questionnarie which is included age, occupation, education, vaccination status and risk factors were applied to the pregnant women. After in the questionnaire, the blood samples which were taken from pregnant women were evaluated in terms of HBsAg, anti- HBs, anti-HBcIgG, anti-HCV and anti-HAV IgG antibodies. Blood samples were evaluated by ELISA technique. Results: The mean age of 2003 pregnant women participated in the study was detected as 27±3 (18- 44) years. In terms of occupational distribution, 89.70% were housewives, 5.4% were workers, 3.6% were freelancers, 1.1% were officers and 0.2% were students. As risk factors, being an intrafamilial transmitted hepatitis carrier was 3.6%, having had c-section was 9.4%, having had other operations 4.3%. Four percent of pregnant women had history of hepatitis B vaccinetion. It was detected to HBsAg positivity in 1.14%, anti-HBs posivity in 17% (past and recovered infection or vaccination), both anti- HBcIgG and anti-HBs positivity in 13.4%, anti-HBs positivity in 3.6%, anti-HCV positivity in 0.7% and anti-HAV IgG positivity in 88.2% . Conclusion: Based on the rate of salt anti- HBs (3.6%), the low rate of HBsAg positivity was not associated with efficient vaccination. Low HBsAg positivity suggests that pregnant women who participated in our study were aware of prevention of hepatitis andits transmission paths. It has been contemplated that other hepatitis seroprevalence studies that will be carried out will contribute health policies in terms of public health.